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A series of previously unknown pyrimidin-2(1H)-ones containing chiral amino acid fragments was
synthesized from 1,1,3,3-tetramethoxypropane and N-carbamoyl derivatives of amino acids under
acidic conditions.
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Introduction
Amino acid derivatives of pyrimidinones are nucle-
oside analogs and are interesting as biologically ac-
tive compounds or their precursors [1]. It is known
that pyrimidin-2(1H)-ones 1 containing peptide frag-
ments reveal anti-inflammatory activity [2]. Their aza
analogs – 1.2.4-triazin-3(2H)-ones 2 – do not show
or show only low anti-inflammatory activity, however
these compounds have been proved to show strong
analgesic properties [3]. Pyrimidinones 3 are useful in
the treatment or prevention of the diseases mediated by
the activation of the β3-adrenoceptor [4, 5].
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The published methods [1 – 4] for the synthesis of
compounds 1–3 lead to products with racemic amino
acid fragments, but it is known that chirality is im-
portant for bioactivity. To the best of our knowl-
edge only few methods of synthesis of chiral α-amino
acid derivatives of pyrimidines are known [6 – 8]. One
method of synthesis of pyrimidines with chiral α-
amino acid fragments at the heterocyclic ring has been
reported. The alkylation of cytosine with esters of
(S)-lactic acid leads to alkyl derivatives of cytosine
(de= 56) [8].
Results and Discussion
In this work the synthesis of pyrimidin-2(1H)-
ones with amino acid residues is described. It is
known that N-carbamoyl amino acids easily cyclize to
give hydantoins under acidic conditions [9, 10]. The
condensation of 1,1,3,3-tetramethoxypropane with N-
carbamoyl derivatives of amino acids in the presence
of hydrochloric acid in methanol gives methyl esters
of pyrimidinones 5–11 (Scheme 1, Fig. 1). The change
of solvent from methanol to ethanol, 2-propanol or
water leads to the disappearance of pyrimidinones in
the products of the reaction. In the reactions with N-
carbamoyl derivatives of other amino acids such as L-
valine, L-leucine, L-isoleucine, D,L-tryptophan, or L-
serine we failed to obtain the corresponding pyrimidi-
nones. Acid hydrolysis of the esters 5 and 6 leads to
carboxylic acids 12 (67%) and 13 (76%), respectively
(Scheme 1).
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R Configuration Product Yield (%) 
CH3 (S) 5 43 
CH3 (R) 6 21 
CH2CH2SCH3 (S) 7 55 
CH2CH2SCH3 (R) 8 15 
CH2CH2SCH3 (R,S) 9 34 
CH2Ph (R,S) 10 40 
CH2(p-C6H4OH) (S) 11 52 
Scheme 1. Synthesis of pyrimidin-2(1H)-one derivatives.
Fig. 1. ORTEP diagram of 7.
In addition we tried to prepare 1-substituted
pyrimidin-2-ones from 2-phenylmalonaldehyde 14.
When a mixture of 2-phenylmalonaldehyde and a sub-
stituted urea was refluxed in toluene in the pres-
ence of p-TsOH [11] hydantoins were formed as the
sole products from the N-carbamoyl derivatives of L-
methionine, L-lysine, L-leucine, L-isoleucine, and L-
tyrosine. Using different reaction times in the reaction
with L-valine led to the products 15 and 16 besides the
corresponding hydantoin derivative (Scheme 2).
Obviously the first step of the reaction leads to the
condensation product 15 (Fig. 2). Under forced condi-
tions 15 is cyclized and subsequently decarboxylated
to give 16 (Fig. 3). We could not find conditions which
allowed the isolation of an intermediate. When ben-
zene or p-xylene were used as solvents, hydantoins
were the sole reaction products.
Experimental Section
All commercially obtained solvents and reagents were
used as received; N-carbamoyl amino acids [12] and 2-
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Scheme 2.
Fig. 2. ORTEP diagram of 15.
phenylmalonaldehyde [11] were synthesized by known
methods. 1H, 13C NMR spectra were recorded on a Bruker
DRX-400 spectrometer; tetramethylsilane (TMS) was used
as an internal standard. The optical rotation was measured on
a Perkin Elmer polarimeter. Mass spectra were recorded on
a Bruker Daltonics MicroTOF-Q II mass spectrometer with
electrospray ionization.
General procedure for the synthesis of compounds 5–11
1,1,3,3-Tetramethoxypropane (821 µL, 5.0 mmol) and
conc. HCl (12 M, 3 mL) were added to a suspension of
the corresponding N-carbamoyl amino acid (5.0 mmol) in
methanol (10 mL). After a few minutes a colorless suspen-
sion resulted, which turned to a clear yellow solution on
stirring at ambient temperature for 1 day. Then it was neu-
tralized with saturated aqueous NaHCO3. After evaporation
of methanol the solution was diluted with 40 mL of water
and extracted three times with CHCl3 (50 mL). The organic
layer was separated, washed with water and brine and dried
over Na2SO4. The CHCl3 was evaporated, and the residue
was chromatographed on a silica gel column with EtOAc as
an eluent (5–9). Compounds 10, 11 were crystallized from
ethanol.
Fig. 3. ORTEP diagram of 16.
(S)-2-(2-Oxopyrimidin-1(2H)-yl)propionic acid methyl ether
(5)
Colorless liquid. Yield 0.39 g (43%). – 1H NMR
(400 MHz, [D6]DMSO): δ = 1.67 (d, J = 7.4 Hz, 3H, CH3),
3.76 (s, 3H, OCH3), 5.41 (q, J = 7.4 Hz, 1H, CH), 6.38 (dd,
J = 6.7, 4.1 Hz, 1H, Py-H), 7.74 (dd, J = 6.7, 2.8 Hz, 1H,
Py-H), 8.60 (dd, J = 3.9, 2.9 Hz, 1H, Py-H). – 13C NMR
(100 MHz, [D6]DMSO) δ = 16.5, 53.0, 55.6, 104.2, 145.4,
155.7, 166.1, 170.4. –C8H10N2O3: calcd. C 52.74, H 5.53,
N 15.38; found C 52.99, H 5.67, N, 15.45.
(R)-2-(2-Oxopyrimidin-1(2H)-yl)propionic acid methyl ester
(6)
Colorless liquid. Yield 0.19 g (21%). – 1H NMR
(400 MHz, [D6]DMSO) δ = 1.67 (d, J = 7.4 Hz, 3H, CH3),
3.76 (s, 3H, OCH3), 5.41 (q, J = 7.4 Hz, 1H, CH), 6.38 (dd,
J = 6.7, 4.1 Hz, 1H, Py-H), 7.74 (dd, J = 6.7, 2.8 Hz, 1H,
Py-H), 8.60 (dd, J = 3.9, 2.9 Hz, 1H, Py-H). –C8H10N2O3:
calcd. C 52.74, H 5.53, N 15.38; found C 52.82, H 5.70, N
15.27.
(S)-4-(Methylthio)-2-(2-oxopyrimidin-1(2H)-yl)butyric acid
methyl ester (7)
Colorless crystals. Yield 0.67 g (55%); m. p. 129 ◦C. –
[α]D = −100.8 (c = 1.0, MeOH). – 1H NMR (400 MHz,
[D6]DMSO): δ = 2.01 (s, 3H, SCH3), 2.32 – 2.44 (m, 4H,
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7 15 16
Empirical formula C10H14N2O3S C15H18N2O4 C14H16N2O
Mr 242.29 290.31 228.29
Crystal size, mm3 0.25× 0.13 × 0.07 0.24× 0.13× 0.08 0.44× 0.21× 0.07
Crystal system orthorhombic monoclinic triclinic
Space group P212121 P21 P¯1
a, A˚ 6.1061(3) 6.5984(3) 6.2046(12)
b, A˚ 13.8993(13) 11.9696(5) 9.368(3)
c, A˚ 14.5862(10) 9.9658(4) 11.194(2)
α , deg 90.0 90.0 93.098(19)
β , deg 90.0 93.980(3) 103.775(17)
γ , deg 90.0 90.0 102.96(2)
V , A˚3 1237.94(16) 785.20(6) 611.9(2)
Z 4 2 2
Dcalcd., g cm−3 1.30 1.23 1.24
µ(MoKα ), cm−1 0.3 0.1 0.1
F(000), e 512 308 244
hkl range +8→−6, ±19, ±20 ±8, ±14, +12→−11 +7→−6, ±11, ±13
θ range, deg 2.79 – 30.52 2.66 – 26.36 2.76 – 26.37
Refl. measured/unique 3691/2554 1669/1283 2481 /1184
Rint 0.0165 0.0161 0.0236
Param. refined 147 206 154
R(F)/wR(F2)a (all refl.) 0.0575/0.0954 0.0368/0.0557 0.0870/0.0666
GoF (F2)b 1.002 1.006 1.007
∆ρfin (max/min), e A˚−3 −0.25/0.22 −0.11/0.09 −0.13/0.10
a R(F) =‖ Fo|−|Fc ‖ /Σ|Fo|, wR(F2) = [Σw(F2o −F2c )2/Σw(F2o )2]1/2, w= [σ2(F2o )+(AP)2+BP]−1,
where P = (Max(F2o ,0)+2F2c )/3; b GoF = [Σw(F2o −F2c )2/(nobs−nparam)]1/2.
Table 1. Crystal structure data
for 7, 15, and 16.
CH2), 3.65 (s, 3H, OCH3), 5.12 (t, J = 6.9 Hz, 1H, CH), 6.51
(dd, J = 6.5, 4.1 Hz, 1H, Py-H), 8.22 (dd, J = 6.5, 2.8 Hz,
1H, Py-H), 8.60 (dd, J = 4.1, 2.8 Hz, 1H, Py-H). – 13C NMR
(100 MHz, [D6]DMSO): δ = 14.9, 28.0, 29.8, 53.0, 61.9,
104.7, 149.9, 155.6, 167.3, 169.7. – C10H14N2O3S: calcd.
C 49.57, H 5.82, N 11.56; found C 49.52, H 5.88, N 11.89.
(R)-4-(Methylthio)-2-(2-oxopyrimidin-1(2H)-yl)butyric acid
methyl ester (8)
Colorless crystals. Yield 0.18 g (15%); m. p. 133 ◦C. –
[α]D = +94.3 (c = 1.0, MeOH). – 1H NMR (400 MHz,
[D6]DMSO): δ = 2.04 (s, 3H, SCH3), 2.29 – 2.44 (m, 4H,
CH2), 3.69 (s, 3H, OCH3), 5.05 – 5.08 (m, 1H, CH), 6.43 (dd,
J = 6.5, 4.1 Hz, 1H, Py-H), 8.15 (dd, J = 6.5, 2.8 Hz, 1H, Py-
H), 8.55 (dd, J = 4.0, 2.8 Hz, 1H, Py-H). – C10H14N2O3S:
calcd. C 49.57, H 5.82, N 11.56; found C 49.64, H 5.93, N
11.70.
(R,S)-4-(Methylthio)-2-(2-oxopyrimidin-1(2H)-yl)butyric
acid methyl ester (9)
Colorless crystals. Yield 0.41 g (34%); m. p. 105 ◦C. –
1H NMR (400 MHz, [D6]DMSO): δ = 2.04 (s, 3H, SCH3),
2.32 – 2.43 (m, 4H, CH2), 3.69 (s, 3H, OCH3), 4.97 – 5.16
(m, 1H, CH), 6.43 (dd, J = 6.5, 4.1 Hz, Py-H), 8.15 (dd, J =
6.5, 2.8 Hz, Py-H), 8.56 (dd, J = 4.1, 2.8 Hz, Py-H). – 13C
NMR (100 MHz, [D6]DMSO): δ = 14.9, 28.1, 29.9, 53.0,
61.9, 104.6, 149.8, 155.6, 167.3, 169.7. – HRMS ((+)-ESI-
MS): m/z = 243.0848 (calcd. 243.0798 for C10H15N2O3S,
[M+H]+). – C10H14N2O3S: calcd. C 49.57, H 5.82, N
11.56; found C 49.54, H 5.86, N 11.60.
(R,S)-2-(2-Oxopyrimidin-1(2H)-yl)-3-phenylpropionic acid
methyl ester (10)
Colorless crystals. Yield 0.52 g (40%); m. p. 162 ◦C.
– [α]D = 0 (c = 1.0, MeOH). – 1H NMR (400 MHz,
[D6]DMSO): δ = 3.36 – 3.46 (m, 2H, CH2), 3.71 (s, 3H,
OCH3), 5.19 (dd, J = 10.1, 5.7 Hz, 1H), 6.16 (dd, J = 6.5,
4.1 Hz, 1H), 7.04 – 7.11 (m, 2H), 7.12 – 7.21 (m, 3H), 7.74
(dd, J = 6.5, 2.8 Hz, 1H), 8.42 (dd, J = 4.1, 2.8 Hz, 1H).
–
13C NMR (100 MHz, [D6]DMSO): δ = 33.5, 52.4, 64.0,
103.5, 126.7, 128.4, 128.9, 136.1, 149.5, 154.9, 166.6, 168.7.
– HRMS ((+)-ESI-MS): m/z = 259.1094 (calcd. 259.1077
for C14H15N2O3, [M+H]+).
(S)-3-(4-Hydroxyphenyl)-2-(2-oxopyrimidin-
1(2H)-yl)propionic acid methyl ester (11)
Colorless crystals. Yield 0.71 g (52%); m. p. 166 ◦C. –
[α]D = −242.9 (c = 1.0, MeOH). – 1H NMR (400 MHz,
[D6]DMSO): δ = 3.22 – 3.33 (m, 2H), 3.67 (s, 3H, OCH3),
5.16 (dd, J = 10.2, 5.6 Hz), 6.28 (dd, J = 6.5, 4.2 Hz), 6.59
(d, J = 8.3 Hz, 2H, 4-OH-Ph), 6.85 (d, J = 8.3 Hz, 2H,
4-OH-Ph), 7.81 (dd, J = 6.5, 2.7 Hz, 1H), 8.47 – 8.49 (m,
1H), 9.22 (s, 1H). – 13C NMR (100 MHz, [D6]DMSO):
δ = 32.7, 52.3, 64.1, 103.5, 115.2, 125.9, 129.8, 149.5,
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154.9, 156.0, 166.5, 168.8. – HRMS ((+)-ESI-MS): m/z =
275.1044 (calcd. 275.1026 for C14H15N2O4, [M+H]+).
Procedure for the synthesis of 12 and 13
Conc. HCl (3 mL) was added to the solution of pyrim-
idinone 5 or 6 (200 µg) in dioxane (10 mL). The reaction
mixture was stirred for 1 day, and then it was evaporated in
a Petri dish to dryness and crystallized from 2-propanol.
(S)-2-(2-Oxopyrimidin-1(2H)-yl)propionic acid (12)
Colorless crystals. Yield 0.12 g (67%); m. p. 179 ◦C. –
[α]D = −39.4 (c = 1.0, MeOH). – 1H NMR (400 MHz,
[D6]DMSO): δ = 1.66 (d, J = 7.3 Hz, 3H, CH3), 5.21 (q, J =
7.2 Hz, 1H), 6.72 (dd, J = 6.4, 5.0 Hz, 1H), 8.63 – 8.70 (m,
1H), 8.73 (dd, J = 4.7, 2.6 Hz, 1H). – 13C NMR (100 MHz,
[D6]DMSO): δ = 15.4, 59.0, 104.7, 150.5, 156.0, 162.3,
170.6. – HRMS ((+)-ESI-MS): m/z = 169.0616 (calcd.
169.0608 for C7H9N2O3, [M+H]+). – C7H8N2O3: calcd.
C 50.00, H 4.80, N 16.66; found C 50.12, H 4.93, N 16.77.
(R)-2-(2-Oxopyrimidin-1(2H)-yl)propionic acid (13)
Colorless crystals. Yield 0.14 g (76%); m. p.
183 – 184 ◦C. – [α]D = +37.1 (c = 1.0, MeOH). – 1H
NMR (400 MHz, [D6]DMSO): δ = 1.65 (d, J = 7.3 Hz,
3H, CH3), 5.20 (q, J = 7.3 Hz, 1H, CH), 6.70 (dd, J = 6.3,
5.0 Hz, 1H, Py-H), 8.66 (dd, J = 6.4, 2.5 Hz, 1H, Py-H),
8.72 (dd, J = 4.8, 2.6 Hz, 1H, Py-H). – C7H8N2O3: calcd.
C 50.00, H 4.80, N 16.66; found C 49.59, H 5.02, N 16.72.
Procedure for the synthesis of compounds 15 and 16
2-Phenylmalonaldehyde (1.0 g, 6.75 mmol) and N-
carbamoyl L-valine (1.62 g, 10.12 mmol) were mixed with
toluene (60 mL). The mixture was refluxed with a Dean-Stark
trap. Then it was cooled to 40 ◦C, the toluene solution was
decanted, and the resin residue was crystallized from ethanol.
(2S)-3-Methyl-2-((E)-3-(3-oxo-2-phenylpropylidene)-
ureido)butyric acid (15)
Colorless crystals. Yield 0.15 g (8%); m. p. 203 – 204 ◦C.
–
1H NMR (400 MHz, [D6]DMSO): δ = 0.85 (d, J = 6.8 Hz,
3H, CH3), 0.92 (d, J = 6.8 Hz, 3H, CH3), 2.04 – 2.21 (m,
1H, CH), 4.17 – 4.20 (m, 1H, CH), 7.21 – 7.23 (m, 2H, Ph),
7.34 – 7.46 (m, 4H, Ph), 7.77 (d, J = 12.4 Hz, 1H), 9.14 (d,
J = 12.4 Hz, 1H), 9.31 (s, 1H, COOH), 12.63 (br.s, 1H, NH).
– HRMS ((+)-ESI-MS): m/z = 291.1320 (calcd. 291.1339
for C15H19N2O4, [M+H]+).
1-Isobutyl-5-phenylpyrimidin-2(1H)-one (16)
Yellow crystals. Yield 0.20 g (13%); m. p. 177 ◦C. – 1H
NMR (400 MHz, [D6]DMSO): δ = 0.95 (d, J = 6.7 Hz, 6H,
2×CH3), 2.10 – 2.28 (m, 1H, CH), 3.77 (d, J = 7.4 Hz,
1H, CH2), 7.29 – 7.33 (m, 1H, Ph), 7.40 – 7.44 (m, 2H, Ph),
7.55 – 7.57 (m, 2H, Ph), 8.48 (d, J = 3.4 Hz, 1H), 8.87 (d,
J = 3.4 Hz, 1H). – 13C NMR (100 MHz, [D6]DMSO): δ =
164.8, 155.6, 147.4, 133.7, 129.5, 127.9, 125.8, 116.6, 57.9,
27.4, 19.9. – HRMS ((+)-ESI-MS): m/z = 229.1352 (calcd.
229.1335 for C14H17N2O, [M+H]+).
Crystal structure determinations
X-Ray analyses were carried out on an Oxford Diffraction
Xcalibur S CCD diffractometer using the software package
CRYSALISPRO [13]. X-Ray data collection was carried out
at 295(2) K with graphite-monochromatized MoKα radiation
(λ = 0.71073 A˚). The structures were solved with Direct
Methods using SHELXS-97 [14] and refined by full-matrix
least-squares procedures on F2 with SHELXL-97 [15]. Non-
H atoms were refined anisotropically, hydrogen atoms were
placed in idealized positions and were constrained to ride on
their parent atoms. Due to the absence of heavy atoms in the
non-centrosymmetric crystal structures of 7 and 15, Friedel
pairs were merged, and Flack parameters were not refined.
Table 1 summarizes the crystal data and numbers pertinent
to data collection and structure refinement.
CCDC 873468 (7), CCDC 936498 (15) and CCDC
936499 (16) contain the supplementary crystallographic data
for this paper. These data can be obtained free of charge from
The Cambridge Crystallographic Data Centre via www.ccdc.
cam.ac.uk/data request/cif.
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